Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/34166
Tipo
ArtículoDerechos de autor
Acceso restringido
Fecha del embargo
2025-01-01
Colecciones
- IOC - Artigos de Periódicos [12642]
Metadatos
Mostrar el registro completo del ítem
VIRAL SEQUENCE EVOLUTION IN ACUTE HEPATITIS C VIRUS INFECTION
Autor
Afiliación
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
University Hospital Essen. Department of Virology. Essen, Germany.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Virologia. Rio de Janeiro, RJ. Brasil.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA / Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School. Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
University Hospital Essen. Department of Virology. Essen, Germany.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Virologia. Rio de Janeiro, RJ. Brasil.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA / Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School. Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Partners AIDS Research Center. Infectious Disease Division, Massachusetts General Hospital. Harvard Medical School, Boston, Massachusetts, USA.
Resumen en ingles
CD8(+)-T-cell responses play an important role in the containment and clearance of hepatitis C virus (HCV) infection, and an association between viral persistence and development of viral escape mutations has been postulated. While escape from CD8+ -T-cell responses has been identified as a major driving force for the evolution of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV), a broader characterization of this relationship is needed in HCV infection. To determine the extent, kinetics, and driving forces of HCV sequence evolution, we sequenced the entire HCV genome longitudinally in four subjects monitored for up to 30 months after acute infection. For two subjects the transmission sources were also available. Of 53 total non-envelope amino acid substitutions detected, a majority represented forward mutations away from the consensus sequence. In contrast to studies in HIV and SIV, however, only 11% of these were associated with detectable CD8+ T-cell responses. Interestingly, 19% of non-envelope mutations represented changes toward the consensus sequence, suggesting reversion in the absence of immune pressure upon transmission. Notably, the rate of evolution of forward and reverse mutations correlated with the conservation of each residue, which is indicative of structural constraints influencing the kinetics of viral evolution. Finally, the rate of sequence evolution was observed to decline over the course of infection, possibly reflective of diminishing selection pressure by dysfunctional CD8+ T cells. Taken together, these data provide insight into the extent to which HCV is capable of evading early CD8+ T-cell responses and support the hypothesis that dysfunction of CD8+ T cells may be associated with failure to resolve HCV infections.
Compartir